Septic superior ophthalmic vein thrombosis: To coagulate or not to coagulate?

Clinical and Experimental Ophthalmology

Volumn 30, Issue 6, 2002, Pages 447-449

  Lai, Tze Foon ^a   Wu, Johnny ^a   Henderson, Tim ^a   Winlaw, Wilfred ^a  

^a ALICE SPRINGS HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING; BRAIN HEMORRHAGE; CAVERNOUS SINUS THROMBOSIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; LETTER; MORTALITY; PARTIAL THROMBOPLASTIN TIME; RETINA VEIN; SEPTIC SUPERIOR OPHTHALMIC VEIN THROMBOSIS; SIDE EFFECT; SKIN BRUISING; STRUCTURE ACTIVITY RELATION; VEIN THROMBOSIS;

ANTICOAGULANTS; BACTEREMIA; ENOXAPARIN; HUMANS; ORBIT; ORBITAL DISEASES; STAPHYLOCOCCAL INFECTIONS; VENOUS THROMBOSIS;

EID: 0036919240     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2002.00583.x     Document Type: Letter

References (12)

1. Walker JC, Sandhu A, Pietris G. Septic superior ophthalmic vein thrombosis. Clin. Experiment. Ophthalmol. 2002; 30: 144-6.
2. Sanchez TG, Cahali MB, Murakami MS, Butugan O, Miniti A. Septic thrombosis of orbital vessels due to cutaneous nasal infection. Am. J. Rhinol. 1997; 11: 429-33.
3. Berenholz L, Kessler A, Shlomkovitz N, Sarfati S, Segal S. Superior ophthalmic vein thrombosis: Complication of ethmoidal rhinosinusitis. Arch. Otolaryngol. Head Neck Surg. 1998; 124: 95-7.
4. Ebright JR, Pace MT, Noazi AF. Septic thrombosis of the cavernous sinuses. Arch. Intern. Med. 2001; 161: 2671-6.
5. Southwick FS, Richardson EP, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) 1986; 65: 82-106.
6. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988; 38: 517-22.
7. Mclean J. The thromboplastic action of cephalin. Am. J. Physiol. 1916; 41: 250-57.
8. Weitz JI. Low-molecular-weight heparins. N. Engl. J. Med. 1997; 337: 688-98.
9. Nurmohamed MT, Rosendaal FR, Buller HR et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 1992; 340: 152-6.
10. Juergens CP, Semarian C, Keech AC et al. Haemorrhagic complications of intravenous heparin use. Am. J. Cardiol. 1997; 80: 152-5.
11. Simonneau G, Sors H, Charbonnier B et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N. Engl. J. Med. 1997; 337: 663-9.
12. Hull RD, Raskob GE, Brant RF et al. Low-molecular-weight heparin versus heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch. Intern. Med. 2000; 160: 229-36.